Pharmaceutical Attorneys Dangerous Drugs Defective Medical Devices Medical Conditions Currently Accepted Cases Our Lawyers Do I Have a Case? Contact Us

New Warning for Yasmin, Safyral and Beyaz Users

The risk of Venous Thrombosis (VTE) is now being printed on the warning labels for the drugs Yasmin, Safyral and Beyaz. Venous Thrombosis is a type of blood clot that forms in veins that could possibly be life-threatening. The risk of contracting VTE is 3 to 9 per every 10,000 women and risk is the highest during the first year of use. It is likeliest for a woman to develop VTE after starting the medication for the first time or starting up again after a period of cessation. The same warning was placed on YAZ labels about a year ago, but both warnings do not list anything specific. The change to the warning label was not largely publicized but was simply added to the Food and Drug Administration's website after it was placed on the new birth control inserts.

Many women take birth control pills without adequate warning of the possible health risks they could pose. If you have sustained an injury as a result of taking a prescription drug, then seek the help of a pharmaceutical injury attorney from Arnold & Itkin. Their firm has a successful track-record in going up against big medical companies and obtaining successful settlements for their clients who were victims of dangerous drugs. Every woman should be properly informed about possible health risks they face while taking their birth control pill, and when they are not, they are not at fault for their injuries. Medical manufacturers should always be held accountable for their actions, and if their product caused you harm, you should contact a dangerous drug lawyer from our firm today to see how we can assist you.

Categories: Dangerous Drugs

Comments

No Comments Posted
Boniva May Increase Side Effect Risk
Prescription drugs such as Boniva, Actonel and Fosamax may not only cause some patients' side effects to worsen, they may be doing nothing to impr... Read More [+]
FDA Rejects expanded use of New Blood Thinner
Johnson & Johnson's Xarelto (rivaroxaban) is an anticoagulant (blood thinner) that received Food and Drug Administration (FDA) approval last y... Read More [+]
First Actos Jury Verdict Delivers $6.5 Million to Victim with Bladder Cancer
On April 26, a jury found pharmaceutical giant Takeda liable for injuries, including bladder cancer, sustained by Jack Cooper after taking the company... Read More [+]